Steps on the Path to Clinical Translation: An International Perspective
Member-Initiated Session
Thursday, 09 May 2024
Nicoll 3
16:00 - 18:00
Moderators: Po-Wah
So, Penny Cristinacce & Harpreet Hyare
Session Number: MIS-03
No CME/CE Credit
OVERVIEW:
The potential of quantitative MR (qMR) has not translated into
widespread clinical adoption, with a limited number of qMR
imaging/spectroscopic biomarkers guiding clinical decisions. The
translation of qMR biomarkers requires the knowledge, expertise and
consensus of a broad range of stakeholders including radiologists,
radiographers, research scientists, clinical physicists, imaging
networks, metrologists; as well as the regulatory bodies, healthcare
providers, imaging CROs, health economists and vendors.
Building on the experience of a BIC‐ISMRM chapter workshop held in
Cardiff, UK, in 2022 (https://doi.org/10.1002/mrm.29704), we aim to open
this timely discussion out to the international ISMRM community. At the
previous workshop, survey questions were developed via consensus from a
roundtable discussion of all attendees. The results found 3 main themes:
Consensus (recommendations/frameworks, standardised language), Context
Dependency (biomarker-dependent adaptability), and Product Profile
(defining unmet need and end product) (Markus et al, ISMRM 23, 3391).
Attendees will hear the perspectives of 5 key international voices in
qMR biomarker translation and have the opportunity to participate in a
live, interactive survey throughout the symposium. The results of this
survey, specifically designed to capture an international perspective,
will be used in ongoing work to define a support framework for the
translational pathway of qMR biomarkers.
TARGET AUDIENCE:
Research scientists, clinicians, radiographers, clinical scientists and
other stakeholders interested in the clinical translation of qMR
biomarkers.
AS A RESULT OF ATTENDING THIS COURSE, PARTICIPANTS SHOULD BE ABLE TO:
- Gain an understanding of the opportunities and challenges of clinical
translation of qMR biomarkers from the perspective of key stakeholders;
- Have the opportunity to participate in defining an international
picture of the opportunities and challenges of qMR biomarkers
translation; and
- Input into the next steps for defining a framework to support the
translational pathway for qMR biomarkers.
16:00 |
|
Introduction
|
16:05 |
|
A Radiologist's Perspective
Pek-Lan Khong
National University of Singapore, Singapore
|
16:20 |
|
A Research Radiographer's Perspective
Shawna Farquharson
National Imaging Facility, University of Queensland, St.
Lucia, Australia
|
16:35 |
|
A Clinical Physicist's Perspective
Matthew Grech-Sollars
University College London, London, United Kingdom
|
16:50 |
|
A Metrologist's Perspective
Christoph Kolbitsch
Physikalisch-Technische Bundesanstalt (PTB), Berlin,
Germany
|
17:05 |
|
A Research Scientist’s Perspective
Dan Ma
Case Western Reserve University, Cleveland, OH, United
States
|
17:20 |
|
Panel Discussion & Survey
|